[BioC] Does the strand of a microarray probe matter?
cei at ebi.ac.uk
Wed Nov 19 09:51:39 CET 2008
Related issues have arisen before, where the probe of a particular array
platform was annotated to a gene on the opposite strand. But I was just
asked if this even matters, or should it simply be considered a case of
bad probe design.
Does the protocol for different manufacturer's arrays always produce
amplified product of both strands for the transcript to be measured? I
could imagine that protocols that amplify based on poly-A tails would
tend to produce an anti-sense biased amplification product (older Affy
arrays?), whereas those based on random priming could produce products
of both strands (and so the actual strand that is on the array becomes
Does someone know what is the case in particular for Illumina Beadarrays?
The Wellcome Trust Sanger Institute is operated by Genome Research
Limited, a charity registered in England with number 1021457 and a
company registered in England with number 2742969, whose registered
office is 215 Euston Road, London, NW1 2BE.
More information about the Bioconductor